1st Quarter - Report

FORBES-TATE for EMERGENT BIOSOLUTIONS

Firm
Client
Income
$40,000
Expenses
—

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Disaster Planning/Emergencies DIS

H.R. 6074 - Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020 (Public Law 116-123), H.R. 748 - CARES Act (Public Law 116-136), and FY 2021 Appropriations related to development, acquisition, and stockpiling of medical countermeasures for the U.S. Government; NDAA, provisions related to biological and chemical defense; Issues related to Priority Review Voucher programs; Issues regarding opioid and heroin addiction legislation, naloxone access, co-prescribing, and opioid prescribing guidelines.

LobbyistCovered position, as disclosed
JERRY DRISCOLL —
KRISTINA DUNKLIN —
ELIZABETH GREER —
FRANCESCA MCCRARY New Legislative Assistant, Rep. Elijah Cummings (2016-2017); Professional Staff, House Oversight & Reform Committee (2016)
RICK MURPHY —
EDWARD C. RENO —
JEFFREY SADOSKY —
WESLEY RYAN WELCH —
DERRICK M WHITE —
ZACHARY WILLIAMS —

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Health & Human Services, Dept of (HHS); Justice, Dept of (DOJ); Substance Abuse & Mental Health Services Administration (SAMHSA); Office of Natl Drug Control Policy (NDCP); Office of Management & Budget (OMB); Centers For Disease Control & Prevention (CDC)

Bills named: H.R. 748 (116th), H.R. 6074 (116th)

Health Issues HCR

H.R. 6074 - Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020 (Public Law 116-123), H.R. 748 - CARES Act (Public Law 116-136), and FY 2021 Appropriations related to development, acquisition, and stockpiling of medical countermeasures for the U.S. Government; NDAA, provisions related to biological and chemical defense; Issues related to Priority Review Voucher programs; Issues regarding opioid and heroin addiction legislation, naloxone access, co-prescribing, and opioid prescribing guidelines.

LobbyistCovered position, as disclosed
JERRY DRISCOLL —
KRISTINA DUNKLIN —
ELIZABETH GREER —
FRANCESCA MCCRARY New Legislative Assistant, Rep. Elijah Cummings (2016-2017); Professional Staff, House Oversight & Reform Committee (2016)
RICK MURPHY —
EDWARD C. RENO —
JEFFREY SADOSKY —
WESLEY RYAN WELCH —
DERRICK M WHITE —
ZACHARY WILLIAMS —

Contacted: Justice, Dept of (DOJ); SENATE; Health & Human Services, Dept of (HHS); Office of Management & Budget (OMB); Office of Natl Drug Control Policy (NDCP); Substance Abuse & Mental Health Services Administration (SAMHSA); HOUSE OF REPRESENTATIVES; Centers For Disease Control & Prevention (CDC)

Bills named: H.R. 748 (116th), H.R. 6074 (116th)

Budget/Appropriations BUD

H.R. 6074 - Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020 (Public Law 116-123), H.R. 748 - CARES Act (Public Law 116-136), and FY 2021 Appropriations related to development, acquisition, and stockpiling of medical countermeasures for the U.S. Government; NDAA, provisions related to biological and chemical defense; Issues related to Priority Review Voucher programs; Issues regarding opioid and heroin addiction legislation, naloxone access, co-prescribing, and opioid prescribing guidelines.

LobbyistCovered position, as disclosed
JERRY DRISCOLL —
KRISTINA DUNKLIN —
ELIZABETH GREER —
FRANCESCA MCCRARY New Legislative Assistant, Rep. Elijah Cummings (2016-2017); Professional Staff, House Oversight & Reform Committee (2016)
RICK MURPHY —
EDWARD C. RENO —
JEFFREY SADOSKY —
WESLEY RYAN WELCH —
DERRICK M WHITE —
ZACHARY WILLIAMS —

Contacted: Substance Abuse & Mental Health Services Administration (SAMHSA); Office of Management & Budget (OMB); Centers For Disease Control & Prevention (CDC); HOUSE OF REPRESENTATIVES; Justice, Dept of (DOJ); Office of Natl Drug Control Policy (NDCP); SENATE; Health & Human Services, Dept of (HHS)

Bills named: H.R. 748 (116th), H.R. 6074 (116th)

Homeland Security HOM

H.R. 6074 - Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020 (Public Law 116-123), H.R. 748 - CARES Act (Public Law 116-136), and FY 2021 Appropriations related to development, acquisition, and stockpiling of medical countermeasures for the U.S. Government; NDAA, provisions related to biological and chemical defense; Issues related to Priority Review Voucher programs; Issues regarding opioid and heroin addiction legislation, naloxone access, co-prescribing, and opioid prescribing guidelines.

LobbyistCovered position, as disclosed
JERRY DRISCOLL —
KRISTINA DUNKLIN —
ELIZABETH GREER —
FRANCESCA MCCRARY New Legislative Assistant, Rep. Elijah Cummings (2016-2017); Professional Staff, House Oversight & Reform Committee (2016)
RICK MURPHY —
EDWARD C. RENO —
JEFFREY SADOSKY —
WESLEY RYAN WELCH —
DERRICK M WHITE —
ZACHARY WILLIAMS —

Contacted: Substance Abuse & Mental Health Services Administration (SAMHSA); Justice, Dept of (DOJ); Centers For Disease Control & Prevention (CDC); HOUSE OF REPRESENTATIVES; Office of Management & Budget (OMB); Health & Human Services, Dept of (HHS); Office of Natl Drug Control Policy (NDCP); SENATE

Bills named: H.R. 6074 (116th), H.R. 748 (116th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.